SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT: (DATE OF EARLIEST EVENT REPORTED) : NOVEMBER 11, 2009
COMMISSION FILE NO. 333-136643
ONE BIO, CORP.
- --------------------------------------------------------------------------------
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
Florida 59-3656663
-------- -----------
(STATE OR OTHER JURISDICTION OF (IRS EMPLOYER IDENTIFICATION NO.)
INCORPORATION OR ORGANIZATION)
8525 NW 53rd Terr., Suite C101, Doral, FL 33166
- --------------------------------------------------------------------------------
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
877-544-2288
--------------------------------------
(ISSUER TELEPHONE NUMBER)
ONE HOLDINGS, CORP., 318 Holiday Drive, Hallandale Beach, FL, 33009
- --------------------------------------------------------------------------------
(FORMER NAME AND ADDRESS)
SECTION 8 - OTHER EVENTS
- --------------------------------------------------------------------------------
ITEM 8.01: OTHER ITEMS
On November 16, 2009, FINRA advised the Company that FINRA would process and
effect the Company's name change and the 5 for 1 reverse stock split previously
disclosed in the Company's October 15, 2009, Definitive Information Statement on
Schedule 14(c), relating to an amendment to the Company's articles of
incorporation to: (i) authorize a class of preferred stock consisting of
10,000,000 shares, $0.001 par value per share; (ii) designating 10,000 shares of
the preferred stock as Series A Preferred Stock; (iii) reducing the number of
authorized shares of common stock from 750,000,000 shares to 150,000,000 shares
and changing the par value to $0.001 per share; (iv) changing the name of the
Registrant to ONE Bio, Corp.; and (v) effecting a Five (5) for one (1) reverse
split of the registrant's common stock. Said amendment to the Company's articles
of incorporation was filed on October 26, 2009.
On November 11, 2009, the Company filed an application to list its common stock
on the NASDAQ Capital Market. The Company believes it currently fulfills or will
shortly meet all applicable NASDAQ Capital Market listing requirements. The
Company's listing application is subject to review and approval by NASDAQ's
Listing Qualifications Department for compliance with all NASDAQ Capital Market
standards.
EXHIBITS:
- --------------------------------------------------------------------------------
Exhibit No. Description
3.1 Amendment to Articles of Incorporation filed on October 26, 2009
================================================================================
Signatures
Pursuant to the requirement of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
ONE Bio, Corp.
November 17, 2009 /s/ Marius Silvasan
---------------------------
Marius Silvasan
Chief Executive Officer
and Director
November 17, 2009 /s/ Cris Neely
---------------------------
Cris Neely
Chief Financial Officer
and Director